Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings is a Pharmaceutical company. It focuses on disorders of sleep and wakefulness and currently working to advance the understanding of narcolepsy and provide information and resources to people who live with and healthcare professionals who treat, this chronic, debilitating neurologic disorder. The headquarters is in USA.
The company annual revenue was 437 million USD and net income was 181 million USD as on 2022.